Impact of Genetics and Cannabis on Psychosis Risk
King's College London
2024
n=1592
publication
10 minutes
Evidence: high
Austin-Zimmerman Isabelle, Spinazzola Edoardo, Quattrone Diego, Wu-Choi Beatrice, Trotta Giulia, Li Zhikun, Johnson Emma, Richards Alexander L., Freeman Tom P., Tripoli Giada, Gayer-Anderson Charlotte, Rodriguez Victoria, Jongsma Hannah E., Ferraro Laura, La Cascia Caterina, Tosato Sarah, Tarricone Ilaria, Berardi Domenico, Bonora Elena, Seri Marco, D'Andrea Giuseppe, Szöke Andrei, Arango Celso, Bobes Julio, Sanjuán Julio, Santos Jose Luis, Arrojo Manuel, Velthorst Eva, Bernardo Miguel, Del-Ben Cristina Marta, Rossi Menezes Paulo, Selten Jean-Paul, Jones Peter B., Kirkbride James B., Rutten Bart P. F., Tortelli Andrea, Llorca Pierre-Michel, de Haan Lieuwe, Stilo Simona, La Barbera Daniele, Lasalvia Antonio, Schurnhoff Franck, Pignon Baptiste, van Os Jim, Lynskey Michael, Morgan Craig, EU-GEI WP2 Group, O’ Donovan Michael, Lewis Cathryn M., Sham Pak C., Murray Robin M., Vassos Evangelos, Di Forti Marta
Title
Impact of Genetics and Cannabis on Psychosis Risk
Hypothesis
What is the independent and combined effect of heavy cannabis use and schizophrenia polygenic risk score on the risk for psychotic disorder?
Conclusion
Regular use of high-potency cannabis is a strong predictor of psychotic disorder, independent of genetic risk for schizophrenia.